Please Note: This trial is no longer enrolling new participants
A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma that Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)
| Protocol No. | CTO-EA4232 | Scope | National |
|---|---|---|---|
| Principal Investigator | Utpal Dave | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
